The fibrate drug gemfibrozil disrupts lipoprotein metabolism in rainbow trout

Toxicology and Applied Pharmacology

Volumn 251, Issue 3, 2011, Pages 201-208

  Prindiville, John S ^a   Mennigen, Jan A ^a   Zamora, Jake M ^a   Moon, Thomas W ^a   Weber, Jean Michel ^a  

^a UNIVERSITY OF OTTAWA   (Canada)

Author keywords

Aquatic toxicology; Fatty acid; Fish; Lipid metabolism; PPAR; Triacylglycerol

Indexed keywords

CHOLESTEROL; GEMFIBROZIL; HIGH DENSITY LIPOPROTEIN; LOW DENSITY LIPOPROTEIN; PEROXISOME PROLIFERATOR ACTIVATED RECEPTOR ALPHA; PEROXISOME PROLIFERATOR ACTIVATED RECEPTOR DELTA; PEROXISOME PROLIFERATOR ACTIVATED RECEPTOR GAMMA; PHOSPHOLIPID; TRIACYLGLYCEROL;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; ENZYME ACTIVITY; FEMALE; GENE EXPRESSION; LIPID COMPOSITION; LIPOPROTEIN METABOLISM; NONHUMAN; RAINBOW TROUT;

ANIMALS; FATTY ACIDS; FATTY ACIDS, OMEGA-3; FEMALE; GEMFIBROZIL; GENE EXPRESSION REGULATION; HYPOLIPIDEMIC AGENTS; LIPOPROTEIN LIPASE; LIPOPROTEINS; LIVER; ONCORHYNCHUS MYKISS; PPAR ALPHA; PPAR GAMMA; PPAR-BETA; SEWAGE; WATER POLLUTANTS, CHEMICAL;

ONCORHYNCHUS MYKISS; SALMONIDAE;

EID: 79952002831     PISSN: 0041008X     EISSN: 10960333     Source Type: Journal    
DOI: 10.1016/j.taap.2010.12.013     Document Type: Article

References (46)

1. Abourbih S., Filion K.B., Joseph L., Schiffrin E.L., Rinfret S., Poirier P., Pilote L., Genest J., Eisenberg M.J. Effect of fibrates on lipid profiles and cardiovascular outcomes: a systematic review. Am. J. Med. 2009, 122:e1-e8.
2. Agheli N., Jacotot B. Effect of simvastatin and fenofibrate on the fatty acid composition of hypercholesterolemic patients. Br. J. Clin. Pharmacol. 1991, 32:423-428.
3. Albalat A., Sanchez-Gurmaches J., Gutierrez J., Navarro I. Regulation of lipoprotein lipase activity in rainbow trout (Oncorhynchus mykiss) tissues. Gen. Comp. Endocrinol. 2006, 146:226-235.
4. Andersen O., Eijsink V.G.H., Thomassen M. Multiple variants of the peroxisome proliferator-activated receptor (PPAR) γ are expressed in the liver of Atlantic salmon (Salmo salar). Gene 2000, 255:411-418.
5. Babin P.J., Vernier J.M. Plasma lipoproteins in fish. J. Lipid Res. 1989, 30:467-489.
6. Brown J.N., Paxeus N., Forlin L., Larsson D.G.J. Variations in bioconcentration of human pharmaceuticals from sewage effluents into fish blood plasma. Environ. Toxicol. Pharmacol. 2007, 24:267-274.
7. Despres J.P., Lemieux I., Robins S.J. Role of fibric acid derivatives in the management of risk factors for coronary heart disease. Drugs 2004, 64:2177-2198.
8. Du Z.Y., Demizieux L., Degrace P., Gresti J., Moindrot B., Liu Y.J., Tian L.X., Cao J.M., Clouet P. Alteration of 20:5n-3 and 22:6n-3 fat contents and liver peroxisomal activities in fenofibrate-treated rainbow trout. Lipids 2004, 39:849-855.
9. Du Z.Y., Clouet P., Degrace P., Zheng W.H., Froyland L., Tian L.X., Liu Y.J. Hypolipidaemic effects of fenofibrate and fasting in the herbivorous grass carp (Ctenopharyngodon idella) fed a high-fat diet. Br. J. Nutr. 2008, 100:1200-1212.
10. Forman B.M., Chen J., Evans R.M. Hypolipidemic drugs, polyunsaturated fatty acids, and eicosanoids are ligands for peroxisome proliferator-activated receptors α and δ. Proc. Natl Acad. Sci. USA 1997, 94:4312-4317.
11. Gjoen T., Berg T. Metabolism of high density lipoproteins in rainbow trout. Biochim. Biophys. Acta 1992, 1125:8-12.
12. Havel R.J. Lipid transport function of lipoproteins in blood plasma. Am. J. Physiol. Endocrinol. Metab. 1987, 253:E1-E5.
13. Kolditz C., Borthaire M., Richard N., Corraze G., Panserat S., Vachot C., Lefevre F., Medale F. Liver and muscle metabolic changes induced by dietary energy content and genetic selection in rainbow trout (Oncorhynchus mykiss). Am. J. Physiol. Regul. Integr. Comp. Physiol. 2008, 294:R1154-R1164.
14. Leaver M.J., Tocher D.R., Obach A., Jensen L., Henderson R.J., Porter A.R., Krey G. Effect of dietary conjugated linoleic acid (CLA) on lipid composition, metabolism and gene expression in Atlantic salmon (Salmo salar) tissues. Comp. Biochem. Physiol. A Mol. Integr. Physiol. 2006, 145:258-267.
15. Leaver M.J., Ezaz M.T., Fontagne S., Tocher D.R., Boukouvala E., Krey G. Multiple peroxisome proliferator-activated receptor beta subtypes from Atlantic salmon (Salmo salar). J. Mol. Endocrinol. 2007, 38:391-400.
16. Lindberg A., Olivecrona G. Lipoprotein lipase from rainbow trout differs in several respects from the enzyme in mammals. Gene 2002, 292:213-223.
17. Magnoni L., Weber J.M. Endurance swimming activates trout lipoprotein lipase: plasma lipids as a fuel for muscle. J. Exp. Biol. 2007, 210:4016-4023.
18. Magnoni L.J., Patterson D.A., Farrell A.P., Weber J.M. Effects of long-distance migration on circulating lipids of sockeye salmon (Oncorhynchus nerka). Can. J. Fish. Aquat. Sci. 2006, 63:1822-1829.
19. Magnoni L., Vaillancourt E., Weber J.M. High resting triacylglycerol turnover of rainbow trout exceeds the energy requirements of endurance swimming. Am. J. Physiol. Regul. Integr. Comp. Physiol. 2008, 295:R309-R315.
20. Mandard S., Muller M., Kersten S. Peroxisome proliferator-activated receptor γ target genes. Cell. Mol. Life Sci. 2004, 61:393-416.
21. Manttari M., Huttunen J.K., Koskinen P., Manninen V., Tenkanen L., Heinonen O.P., Frick M.H. Lipoproteins and coronary heart disease in the Helsinki Heart Study. Eur. Heart J. 1990, 11:26-31.
22. Mead J.R., Cryer A., Ramji D.P. Lipoprotein lipase, a key role in atherosclerosis?. FEBS Lett. 1999, 462:1-6.
23. Metcalfe C.D., Koenig B.G., Bennie D.T., Servos M., Ternes T.A., Hirsch R. Occurrence of neutral and acidic drugs in the effluents of Canadian sewage treatment plants. Environ. Toxicol. Chem. 2003, 22:2872-2880.
24. Mimeault C., Woodhouse A., Miao X.S., Metcalfe C.D., Moon T.W., Trudeau V.L. The human lipid regulator, gemfibrozil bioconcentrates and reduces testosterone in the goldfish, Carassius auratus. Aquat. Toxicol. 2005, 73:44-54.
25. Mimeault C., Trudeau V.L., Moon T.W. Waterborne gemfibrozil challenges the hepatic antioxidant defense system and down-regulates peroxisome proliferator-activated receptor beta (PPARβ) mRNA levels in male goldfish (Carassius auratus). Toxicology 2006, 228:140-150.
26. Morash A.J., Kajimura M., McClelland G.B. Intertissue regulation of carnitine palmitoyltransferase I (CPTI): mitochondrial membrane properties and gene expression in rainbow trout (Oncorhynchus mykiss). Biochim. Biophys. Acta 2008, 1778:1382-1389.
27. Nagao K., Sakono M., Nakayama M., Hirakawa T., Imaizumi K. Effect of gemfibrozil on triacylglycerol synthesis and secretion by liver and lipoprotein lipase activity in adipose tissue of rats. Comp. Biochem. Physiol. B Biochem. Mol. Biol. 1999, 124:289-294.
28. Otvos J.D., Collins D., Freedman D.S., Shalaurova I., Schaefer E.J., McNamara J.R., Bloomfield H.E., Robins S.J. Low density lipoprotein and high density lipoprotein particle subclasses predict coronary events and are favorably changed by gemfibrozil therapy in the veterans affairs high-density lipoprotein intervention trial. Circulation 2006, 113:1556-1563.
29. Paxeus N. Removal of selected non-steroidal anti-inflammatory drugs (NSAIDs), gemfibrozil, carbamazepine, beta-blockers, trimethoprim and triclosan in conventional wastewater treatment plants in five EU countries and their discharge to the aquatic environment. Water Sci. Technol. 2004, 50:253-260.
30. Raldua D., Andre M., Babin P.J. Clofibrate and gemfibrozil induce an embryonic malabsorption syndrome in zebrafish. Toxicol. Appl. Pharmacol. 2008, 228:301-314.
31. Rise P., Efigini S., Ghezzi S., Colli S., Galli C. Fatty acid composition of plasma, blood cells and whole blood: relevance for the assessment of the fatty acid status in humans. Prostaglandins Leukot. Essent. Fatty Acids 2007, 76:363-369.
32. Runnalls T.J., Hala D.N., Sumpter J.P. Preliminary studies into the effects of the human pharmaceutical clofibric acid on sperm parameters in adult fathead minnow. Aquat. Toxicol. 2007, 84:111-118.
33. Ruyter B., Andersen O., Dehli A., Farrants A.K.O., Gjoen T., Thomassen M.S. Peroxisome proliferator activated receptors in Atlantic salmon (Salmo salar): effects on PPAR transcription and acyl-CoA oxidase activity in hepatocytes by peroxisome proliferators and fatty acids. Biochim. Biophys. Acta 1997, 1348:331-338.
34. Scarano L.J., Calabrese E.J., Kostecki P.T., Baldwin L.A., Leonard D.A. Evaluation of a rodent peroxisome proliferator in two species of fresh water fish: rainbow trout (Oncorhynchus mykiss) and Japanese medaka (Oryzias latipes). Ecotoxicol. Environ. Saf. 1994, 29:13-19.
35. Shen Y., Lindberg A., Olivecrona G. Apolipoprotein CII from rainbow trout (Oncorhynchus mykiss) is functionally active but structurally very different from mammalian apolipoprotein CII. Gene 2000, 254:189-198.
36. Soria A., Gonzalez M.D., Vidal H., Herrera E., Bocos C. Triglyceridemia and peroxisome proliferator-activated receptor α expression are not connected in fenofibrate-treated pregnant rats. Mol. Cell. Biochem. 2005, 273:97-107.
37. Staels B., Dallongeville J., Auwerx J., Schoonjans K., Leitersdorf E., Fruchart J.G. Mechanism of action of fibrates on lipid and lipoprotein metabolism. Circulation 1998, 98:2088-2093.
38. Tocher D.R. Metabolism and functions of lipids and fatty acids in teleost fish. Rev. Fish. Sci. 2003, 11:107-184.
39. Vazquez M., Merlos M., Adzet T., Laguna J.C. Decreased susceptibility to copper-induced oxidation of rat-lipoproteins after fibrate treatment: influence of fatty acid composition. Br. J. Pharmacol. 1996, 117:1155-1162.
40. Wallaert C., Babin P.J. Circannual variation in the fatty acid composition of high density lipoprotein phospholipids during acclimatization in trout. Biochim. Biophys. Acta 1993, 1210:23-26.
41. Wallaert C., Babin P.J. Age-related, sex-related, and seasonal changes of plasma lipoprotein concentrations in trout. J. Lipid Res. 1994, 35:1619-1633.
42. Wallaert C., Babin P.J. Thermal adaptations affects the fatty acid composition of plasma phospholipids in trout. Lipids 1994, 29:373-376.
43. Wang C.C., Harris W.S., Chung M., Lichtenstein A.H., Balk E.M., Kupelnick B., Jordan H.S., Lau J. n-3 fatty acids from fish or fish-oil supplements, but not alpha-linolenic acid, benefit cardiovascular disease outcomes in primary- and secondary-prevention studies: a systematic review. Am. J. Clin. Nutr. 2006, 84:5-17.
44. Weber J.M. The physiology of long-distance migration: extending the limits of endurance metabolism. J. Exp. Biol. 2009, 212:593-597.
45. Weston A., Caminada D., Galicia H., Fent K. Effects of lipid lowering pharmaceuticals bezafibrate and clofibric acid on lipid metabolism in fathead minnow (Pimephales promelas). Environ. Toxicol. Chem. 2009, 28:2648-2655.
46. Yee M.S., Pavitt D.V., Tan T., Venkatesan S., Godsland I.F., Richmond W., Johnston D.G. Lipoprotein separation in a novel iodixanol density gradient, for composition, density, and phenotype analysis. J. Lipid Res. 2008, 49:1364-1371.